News search

E.g., 28/03/2024
E.g., 28/03/2024
Grupo de Andrés Hidalgo
Andrés Hidalgo
About the CNIC
6 Jul 2022

Through this lifelong honour, new EMBO Members and Associate Members are recognized for their outstanding achievements in the life sciences

Miguel Palomino Segura, Georgiana Crainiciuc, Jon Sicilia y Andrés Hidalgo
Research
5 Jan 2022

Scientists at the CNIC have developed a simple model for studying the behavior of immune cells in live animals and have identified a harmful cell behavior pattern associated with cardiovascular disease


Research
22 Oct 2020

CNIC scientists have discovered previously unsuspected actions of the immune system that help to maintain organ health

Research
16 Sep 2020

The study published in Cell shows that macrophages, a type of immune cell, help cardiac cells to get rid of their waste material, and that this maintains the metabolic and contractile properties of the heart

Andrés Hidalgo
Research
10 Dec 2019

The NeutroCure project focuses on reactive oxygen species (ROS), which play central roles in healthy animals, such as redox signalling to regulate cell growth


Pilar Gonzalo, Rosa Nevado, Ricardo Villa-Bellosta, Magda R. Hamczyk, María J. Andrés-Manzano, and Vicente Andrés.
Research
12 Mar 2019

This new results, published in EMBO Molecular Medicine, identify a possible therapeutic target for this genetic disease

Andrés Hidalgo y José María Adrover+
Research
30 Jan 2019

Neutrophils are the body’s main line of defense, but their action can also damage healthy cells in the cardiovascular system

From left to right: Andrés Hidalgo, Maria Sánchez, Andrea Rubio, Francisco Mayo, Iván Ballesteros, Alejandra Aroca, Georgiana Crainiciuc, Sandra Martín, Juan Quintana, José María Adrover, Itziar Cossío, and Angel Nicolás.
Research
10 Oct 2018

CNIC researchers have discovered that the immune system is important not only in the defense against disease but also for the day-to-day function of a healthy organism

Dr. Andrés Hidalgo
About the CNIC
4 Jul 2018

 ‘Clonal hematopoiesis and atherosclerosis’ will receive a total funding of $6,000,000, of which $712,500 correspond to the CNIC